Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Ovarian Neoplasms × naporafenib × 90 days × Clear all

Sponsor

Conditions

Melanoma 3 Colorectal Neoplasms 2 Thyroid Neoplasms 1 Rectal Neoplasms 1 Pancreatic Neoplasms 1 Neoplasm Metastasis 1 EGFR-mutant Non-small Cell Lung Cancer 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Bevacizumab 29 Paclitaxel 26 olaparib 23 pembrolizumab 21 Specimen Handling 20 Carboplatin 20 Magnetic Resonance Spectroscopy 14 Gemcitabine 12 Biopsy 12 liposomal doxorubicin 11 Taxes 11 Cyclophosphamide 11 Cisplatin 10 niraparib 9 Fulvestrant 9 fludarabine 7 Doxorubicin 6 Topotecan 5 Oxaliplatin 5 Nivolumab 5 Immunoglobulin G 5 Disulfides 5 trastuzumab deruxtecan 4 palbociclib 4 durvalumab 4 atezolizumab 4 aldesleukin 4 X-Rays 4 Standard of Care 4 Platinum 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡